Delivery Order SPE2DB20D3303-SPE2DB24FA2WF

Award Date 9/6/24
Potential Completion Date 9/27/24
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,908.27 firm-fixed-price contract is for the supply of CABOMETYX 60 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of November 13, 2024 and was awarded on October 22, 2024. There is no set-aside designation for this contract. AmerisourceBergen holds a significant $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of CABOMETYX 60 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price of $27,816.56 and a period of performance ending on October 7, 2024. The contract is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order, which is part of a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Cabometyx 60 mg tablets. The contract has a ceiling value of $30,602.10 and a period of performance through May 29, 2025. It is a firm fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $15,346.55 contract is for the supply of CABOMETYX 40 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CABOMETYX 60 MG TABLET 30S. The contract has a ceiling value of $27,816.56 and an ultimate completion date of August 30, 2024. This appears to be a Delivery Order contract with a Firm Fixed Price pricing type. The contract is not set-aside for any special designations. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of CABOMETYX 40 MG TABLET 30S. The contract is a firm fixed-price delivery order with a ceiling value of $13,867.18 and a period of performance through September 26, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CABOMETYX 60 MG TABLET 30S. The contract has a Firm Fixed Price pricing type and a Ceiling Value of $30,602.10. It is not designated as a Set-Aside contract. The contract has an Ultimate Completion Date of April 28, 2025 and was awarded on April 7, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. The total ceiling value of the contract is $28,692.88, with a performance period through January 22, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,301.05, is for the supply of CABOMETYX 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 21, 2025 and is a Firm Fixed Price contract. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $27,734.36. The contract is a firm fixed-price arrangement and runs from the award date of October 22, 2024 through the ultimate completion date of November 13, 2024. The contract was not set aside for any...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA2WF
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug CABOMETYX 20 MG TABLET 30S. The contract has a ceiling value of $28,071.28 and an ultimate completion date of September 27, 2024. The contract was awarded on September 6, 2024 and does not have a set-aside designation. As a large pharmaceutical supplier, AmerisourceBergen has been awarded numerous indefinite delivery contracts (IDCs) by the DLA and other federal agencies to provide a wide range of essential medical commodities, including specialty medications, generic drugs, and medical supplies, to support military treatment facilities, veterans' hospitals, and other government healthcare programs.

Generated 12/6/24, 9:09 AM